Our report aims to enlarge its phenotypic spectrum to encompass major cognitive disorder with very late onset never before reported in conjunction with neurochondrin antibodies.<h4>Methods</h4>We describe the case of an 85-year-old woman who presented in our memory clinic. This evidence concerns the gene NCDN and Cognitive impairment.